down arrow

Tibet Weixinkang Medicine Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QQ3
CNY
11.29
0.04 (0.36%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Tibet Weixinkang Medicine Co., Ltd.
Why is Tibet Weixinkang Medicine Co., Ltd. ?
1
Negative results in Mar 25
  • ROCE(HY) Lowest at 16.23%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 15.45%
  • NET SALES(Q) Lowest at CNY 292.35 MM
2
With ROE of 17.06%, it has a fair valuation with a 3.36 Price to Book Value
  • Over the past year, while the stock has generated a return of 5.32%, its profits have risen by 11.5% ; the PEG ratio of the company is 1.7
  • At the current price, the company has a high dividend yield of 3
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Tibet Weixinkang Medicine Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tibet Weixinkang Medicine Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Tibet Weixinkang Medicine Co., Ltd.
5.32%
0.77
42.01%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.22%
EBIT Growth (5y)
53.44%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.71
Sales to Capital Employed (avg)
0.94
Tax Ratio
10.80%
Dividend Payout Ratio
60.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.01%
ROE (avg)
12.94%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
3.36
EV to EBIT
17.05
EV to EBITDA
13.92
EV to Capital Employed
8.58
EV to Sales
3.21
PEG Ratio
1.71
Dividend Yield
2.97%
ROCE (Latest)
50.31%
ROE (Latest)
17.06%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 330.92 MM

RAW MATERIAL COST(Y)

Fallen by -16.58% (YoY

CASH AND EQV(HY)

Highest at CNY 2,071.35 MM

DEBT-EQUITY RATIO (HY)

Lowest at -71.3 %

DEBTORS TURNOVER RATIO(HY)

Highest at 6.76%

-6What is not working for the Company
ROCE(HY)

Lowest at 16.23%

INVENTORY TURNOVER RATIO(HY)

Lowest at 15.45%

NET SALES(Q)

Lowest at CNY 292.35 MM

Here's what is working for Tibet Weixinkang Medicine Co., Ltd.
Operating Cash Flow
Highest at CNY 330.92 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Cash and Eqv
Highest at CNY 2,071.35 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -71.3 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 6.76%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -16.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tibet Weixinkang Medicine Co., Ltd.
Inventory Turnover Ratio
Lowest at 15.45% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales
Lowest at CNY 292.35 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Net Sales
At CNY 292.35 MM has Fallen at -9.13%
over average net sales of the previous four periods of CNY 321.73 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."